Orthopedic Implants Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Orthopedic Implants Market 

5.1. COVID-19 Landscape: Orthopedic Implants Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Orthopedic Implants Market, By Product

8.1. Orthopedic Implants Market, by Product, 2023-2032

8.1.1. Reconstructive Joint Replacements

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Spinal Implants

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Dental Implants

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Trauma

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Orthobiologics

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Orthopedic Implants Market, By Type

9.1. Orthopedic Implants Market, by Type, 2023-2032

9.1.1. Wrist & Shoulder

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Dental

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Knee

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Hip

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Spine

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Ankle

9.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Orthopedic Implants Market, By Biomaterial 

10.1. Orthopedic Implants Market, by Biomaterial, 2023-2032

10.1.1. Metallic Biomaterials

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Ceramic Biomaterials

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Polymers Biomaterials

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Orthopedic Implants Market, By Procedure

11.1. Orthopedic Implants Market, by Procedure, 2023-2032

11.1.1. Open Surgery

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Minimally Invasive Surgery (MIS)

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Orthopedic Implants Market, By End User

12.1. Orthopedic Implants Market, by End User, 2023-2032

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Orthopedic Clinics

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Home Cares

12.1.3.1. Market Revenue and Forecast (2020-2032)

12.1.4. Others

12.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global Orthopedic Implants Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2020-2032)

13.1.2. Market Revenue and Forecast, by Type (2020-2032)

13.1.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.1.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.1.5. Market Revenue and Forecast, by End User (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.1.6.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.1.7. Market Revenue and Forecast, by End User (2020-2032) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.1.8.2. Market Revenue and Forecast, by Type (2020-2032)

13.1.8.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.1.8.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.1.8.5. Market Revenue and Forecast, by End User (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.2.4. Market Revenue and Forecast, by Procedure (2020-2032) 

13.2.5. Market Revenue and Forecast, by End User (2020-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.2.7. Market Revenue and Forecast, by Procedure (2020-2032) 

13.2.8. Market Revenue and Forecast, by End User (2020-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.2.10. Market Revenue and Forecast, by Procedure (2020-2032)

13.2.11. Market Revenue and Forecast, by End User (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.2.12.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.2.13. Market Revenue and Forecast, by End User (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Type (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.2.14.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.2.15. Market Revenue and Forecast, by End User (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.3.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.3.5. Market Revenue and Forecast, by End User (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.3.6.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.3.7. Market Revenue and Forecast, by End User (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.3.8.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.3.9. Market Revenue and Forecast, by End User (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.3.10.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.3.10.5. Market Revenue and Forecast, by End User (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Type (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.3.11.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.3.11.5. Market Revenue and Forecast, by End User (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.4.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.4.5. Market Revenue and Forecast, by End User (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.4.6.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.4.7. Market Revenue and Forecast, by End User (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.4.8.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.4.9. Market Revenue and Forecast, by End User (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.4.10.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.4.10.5. Market Revenue and Forecast, by End User (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Type (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.4.11.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.4.11.5. Market Revenue and Forecast, by End User (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2020-2032)

13.5.2. Market Revenue and Forecast, by Type (2020-2032)

13.5.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.5.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.5.5. Market Revenue and Forecast, by End User (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Type (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.5.6.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.5.7. Market Revenue and Forecast, by End User (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Type (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Biomaterial (2020-2032)

13.5.8.4. Market Revenue and Forecast, by Procedure (2020-2032)

13.5.8.5. Market Revenue and Forecast, by End User (2020-2032)

Chapter 14. Company Profiles

14.1. Zimmer Biomet Holdings

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Stryker Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Johnson & Johnson

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Medtronic Plc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. NuVasive

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Arthrex, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. DJO Finance LLC

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Smith and Nephew Plc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. CONMED Corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms